Crossmark

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma

Crossref DOI link: https://doi.org/10.1136/jitc-2021-002927

Published Online: 2022-01-11

Published Print: 2022-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Mohsen, Mona O https://orcid.org/0000-0003-3510-9148
Speiser, Daniel E

Michaux, Justine

Pak, HuiSong

Stevenson, Brian J

Vogel, Monique

Inchakalody, Varghese Philipose

de Brot, Simone

Dermime, Said https://orcid.org/0000-0002-5526-7496
Coukos, Georges

Bassani-Sternberg, Michal

Bachmann, Martin F
Funding

Funding for this research was provided by:

Qatar National Research Fund (KFS-4291-08-2017-R)

Qatar National Research Fund (PDRA4-0118-18002)

Swiss Cancer Research Foundation (KFS-5246-02-2021R)
License Information

License valid from 2022-01-11